BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21535981)

  • 1. Physicians' evaluation of clinical pharmacy revealed increased focus on quality improvement and cost savings.
    Kjeldsen LJ; Jensen TB; Jensen JJ
    Dan Med Bull; 2011 May; 58(5):A4261. PubMed ID: 21535981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and financial impact of pharmacy services in the intensive care unit: pharmacist and prescriber perceptions.
    MacLaren R; Brett McQueen R; Campbell J
    Pharmacotherapy; 2013 Apr; 33(4):401-10. PubMed ID: 23468188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical pharmacist in a multidisciplinary team in a paediatric department].
    Kjeldby C; Bjerre A; Refsum N
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1746-9. PubMed ID: 19756055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interdisciplinary patient care in the intensive care unit: focus on the pharmacist.
    Erstad BL; Haas CE; O'Keeffe T; Hokula CA; Parrinello K; Theodorou AA
    Pharmacotherapy; 2011 Feb; 31(2):128-37. PubMed ID: 21275491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How physician and community pharmacist perceptions of the community pharmacist role in Australian primary care influence the quality of collaborative chronic disease management.
    Rieck A; Pettigrew S
    Qual Prim Care; 2013; 21(2):105-11. PubMed ID: 23735691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a fax document for transfer of medication information to family physicians and community pharmacists caring for hemodialysis outpatients.
    Riley KD; Wazny LD
    CANNT J; 2006; 16(1):24-8. PubMed ID: 16615703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of pharmacist interventions.
    Torchinsky A; Landry D
    Can J Hosp Pharm; 1991 Oct; 44(5):245-8, 270. PubMed ID: 10115578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a clinical pharmacist on cost saving and cost avoidance in drug therapy in an intensive care unit.
    Chuang LC; Sutton JD; Henderson GT
    Hosp Pharm; 1994 Mar; 29(3):215-8, 221. PubMed ID: 10132696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
    Muñoz-Pichuante D; Villa-Zapata L
    J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician-patient and pharmacist-patient communication: geriatrics' perceptions and opinions.
    Keshishian F; Colodny N; Boone RT
    Patient Educ Couns; 2008 May; 71(2):265-84. PubMed ID: 18308499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the impact of a clinical pharmacist on the quality and cost of pharmacotherapy in a general surgical department, the Hillel-Yaffe Medical Center].
    Schwartzberg E; Livny S; Sterenberg A; Troitsa A; Oren M; Shani S
    Harefuah; 2003 Jan; 142(1):5-9, 80. PubMed ID: 12647481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-consequences analysis of an adherence focused pharmacist-led medication review service.
    Desborough JA; Sach T; Bhattacharya D; Holland RC; Wright DJ
    Int J Pharm Pract; 2012 Feb; 20(1):41-9. PubMed ID: 22236179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focus and impact of pharmacists' interventions.
    Strong DK; Tsang GW
    Can J Hosp Pharm; 1993 Jun; 46(3):101-8. PubMed ID: 10126864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative study of physicians' and nurses' experiences of multidisciplinary collaboration with pharmacists participating at case conferences.
    Halvorsen KH; Stensland P; Granas AG
    Int J Pharm Pract; 2011 Oct; 19(5):350-7. PubMed ID: 21899615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The integration of quality assessment and a patient-specific intervention/outcomes program.
    Mutnick AH; Sterba KJ; Szymusiak-Mutnick BA
    Pharm Pract Manag Q; 1998 Jan; 17(4):25-36. PubMed ID: 10174746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How a CQI program improved aminoglycoside use in a community hospital.
    Wade WE; McCall CY
    Hosp Formul; 1995 Feb; 30(2):114-6. PubMed ID: 10140350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physicians' expectations towards pharmacy services on ward].
    Bourget S; Allenet B; Bedouch P; Bosson LJ; Calop J
    J Pharm Belg; 2007; 62(4):130-4. PubMed ID: 18269141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pharmacists' clinical interventions on nonformulary drug use.
    Packer LA; Mahoney CD; Rich DS; Jeffrey LP
    Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug utilization & therapeutic intervention programs: pharmacy services that pay for themselves.
    Condron JH; Mann JL
    Can J Hosp Pharm; 1994 Oct; 47(5):203-8. PubMed ID: 10137698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.